Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma
- Carolien C.H.M. Maas*
- , David van Klaveren
- , Müjde Durmaz
- , Otto Visser
- , Djamila E. Issa
- , Eduardus F.M. Posthuma
- , Josée M. Zijlstra
- , Martine E.D. Chamuleau
- , Pieternella J. Lugtenburg
- , Marie José Kersten
- , Avinash G. Dinmohamed*
*Corresponding author for this work
- Netherlands Comprehensive Cancer Organization (IKNL)
- Amsterdam UMC
- Jeroen Bosch Ziekenhuis
- Reinier de Graaf Groep
- Leiden University
Research output: Contribution to journal › Article › Academic › peer-review
3
Citations
(Scopus)
28
Downloads
(Pure)